Pharmaceutical News

RSS

Novel ACE2-blocking antibody protects against all SARS-CoV-2 VOCs

Researchers identify 87G7, a SARS-CoV-2 neutralizing human monoclonal antibody with remarkable broad-spectrum neutralization and protection efficacy.

21 Feb 2022

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

researchers determine the strong neutralizing mucosal component emanating from intramuscular administration of an mRNA vaccine.

21 Feb 2022

Analysis reveals the truth about FDA's expedited approval processes and patient access

University of Illinois Chicago researchers studied 135 products that received U.S. Food and Drug Administration approval through orphan drug and expedited approval program designations.

21 Feb 2022

European research project focuses on fighting against new psychoactive drugs

Promoting the fight against the use of drugs of abuse, anticipating to the appearance of new psychoactive drugs and assessing the risks these have on human health are the main objectives of the European research project approved by the European Commission and led by the Research Group on Neuropsychopharmacology of Amphetamine Derivatives of the University of Barcelona.

21 Feb 2022

Expert highlights the racist origins of US drug policy and its effect on the modern opioid epidemic

In his work as a pain management pharmacist, Dan Arendt has seen some of his patients stigmatized as "drug seekers" or blamed for their use of opioids rather than being acknowledged as a person who is suffering from a severely painful condition.

21 Feb 2022

Full schedule of CoronaVac vaccine shown to be highly effective in children

A recent study on vaccine effectiveness showed that a complete primary immunization with CoronaVac effectively protects against severe coronavirus disease 2019 (COVID-19) for children and adolescents between 6 and 16 years of age – consistent with the results from phase 2 clinical trials. The paper is currently available on the Preprints with The Lancet* server while it undergoes peer review.

20 Feb 2022

N-glycosylation blockers reduce SARS-CoV-2 infection

A new Virology study shows that the N-glycosylation pattern of SARS-CoV-2 is crucial to normal spike activity.

20 Feb 2022

Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate

Researchers have developed a new vaccine candidate that is specifically targeted against the SARS-CoV-2 Omicron variant.

20 Feb 2022

Researchers use an integrated approach to reveal constituents in a multi-herb Chinese medicine

Rooted in ancient knowledge and principles, traditional Chinese medicine (TCM) has been used to treat many diseases, sparking the interest of pharmaceutical researchers. TCM formulas are quite complex, requiring multiple herbs for their formulation.

18 Feb 2022

Prescribing of ineffective COVID drugs could have been influenced by political affiliation

Two treatments that have been shown to be ineffective against COVID-19—hydroxychloroquine and ivermectin—were more heavily prescribed in the latter part of 2020 in U.S. counties with a higher Republican vote share in the 2020 presidential election, according to a new research letter co-authored by researchers from Harvard T.H. Chan School of Public Health.

18 Feb 2022

Ensitrelvir, a novel SARS-CoV-2 antiviral

S-217622 reduces the viral load and help alleviate the severity of SARS-CoV-2 in infected hamsters.

17 Feb 2022

Cessation of antibiotic prophylaxis in dentistry led to no increase in infective endocarditis

Sweden is one of the few countries that have removed the dental health recommendation to give prophylactic antibiotics to people at a higher risk of infection of the heart valves, so-called infective endocarditis.

17 Feb 2022

Study looks at COVID-19 vaccine hesitancy in France and Italy

A recent study posted to Research Square* preprint server, and under consideration at the journal Scientific Reports, aimed to learn more about how and to what extent vaccine hesitancy can alter over time at the individual level by considering parameters such as dynamic preferences, news reporting, and gender influence.

16 Feb 2022

Single dose of BNT162b2 vaccine after COVID provides 82% reduction in reinfection risk

Researchers compare the incidence rate of reinfection in convalescent and unvaccinated people to that in recovered and single-dose vaccinated people.

16 Feb 2022

Omicron breakthrough boosts neutralization titers a little more than a 3rd COVID vaccine dose

Researchers compare the neutralizing antibody titers in individuals who received two or three mRNA vaccine doses and experienced breakthrough infections.

16 Feb 2022

Study analyzes trends in overdose deaths from use of non-benzodiazepines and gabapentinoids

With an alarming rise in the number of prescriptions filled for non-benzo sleeping/z-drugs and anti-epilepsy gabapentinoids over the last two decades, researchers at Columbia University Mailman School of Public Health aimed to fill in the gap in knowledge in the proportion of overdose deaths involving those medications and learn more about their co-usage with other substances across U.S. demographics categories.

16 Feb 2022

Pharmaceutical News

Novel ACE2-blocking antibody protects against all SARS-CoV-2 VOCs

Study reports potently neutralizing mucosal IgA in saliva of BNT162b2 vaccine recipients

Analysis reveals the truth about FDA's expedited approval processes and patient access

European research project focuses on fighting against new psychoactive drugs

Expert highlights the racist origins of US drug policy and its effect on the modern opioid epidemic

Full schedule of CoronaVac vaccine shown to be highly effective in children

N-glycosylation blockers reduce SARS-CoV-2 infection

Researchers develop novel anti-SARS-CoV-2 Omicron vaccine candidate

Researchers use an integrated approach to reveal constituents in a multi-herb Chinese medicine

Prescribing of ineffective COVID drugs could have been influenced by political affiliation

Ensitrelvir, a novel SARS-CoV-2 antiviral

Cessation of antibiotic prophylaxis in dentistry led to no increase in infective endocarditis

Study looks at COVID-19 vaccine hesitancy in France and Italy

Single dose of BNT162b2 vaccine after COVID provides 82% reduction in reinfection risk

Omicron breakthrough boosts neutralization titers a little more than a 3rd COVID vaccine dose

Study analyzes trends in overdose deaths from use of non-benzodiazepines and gabapentinoids

Study shows the true prevalence of statin intolerance worldwide is between 6 to 10%

Inside the tactical tug of war over the controversial Alzheimer’s drug

Two doses of psilocybin may ease depression symptoms for up to 12 months

The in vitro selection of a remdesivir-resistant SARS-CoV-2 mutation

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News